These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6396527)

  • 21. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposite effects of antidepressants and corticosterone on the sensitivity of hippocampal CA1 neurons to 5-HT1A and 5-HT4 receptor activation.
    Bijak M; Zahorodna A; Tokarski K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):491-8. PubMed ID: 11383709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-anxiolytic interactions: involvement of the benzodiazepine-GABA and serotonin systems.
    Suranyi-Cadotte BE; Bodnoff SR; Welner SA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):633-54. PubMed ID: 1705717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-depressant treatments and serotonin receptor number and function.
    Green AR
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():128-37. PubMed ID: 2858955
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of tianeptine and other antidepressants on a rat model of depression.
    Curzon G; Kennett GA; Sarna GS; Whitton PS
    Br J Psychiatry Suppl; 1992 Feb; (15):51-5. PubMed ID: 1356358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical action mechanisms and pharmacokinetics of psychoactive drugs].
    Matussek N; Greil W
    Arzneimittelforschung; 1975 Jul; 25(7a):1178-84. PubMed ID: 1101905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuropharmacological analysis of participation of the serotoninergic system in hyperalgesia in neurotized rats].
    Kudriashova MF; Andreev BV
    Ross Fiziol Zh Im I M Sechenova; 2000 Feb; 86(2):216-8. PubMed ID: 10808514
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of serotonin neurotransmission by antidepressant drugs and electroconvulsive shock: the fall and rise of serotonin receptors.
    Kellar KJ; Stockmeier CA; Gomez JM
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():138-45. PubMed ID: 2984881
    [No Abstract]   [Full Text] [Related]  

  • 29. The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxiety.
    Argyropoulos SV; Sandford JJ; Nutt DJ
    Pharmacol Ther; 2000 Dec; 88(3):213-27. PubMed ID: 11337026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Indolylsuccinimides and 3-(3-pyrrolidinyl)indoles.
    Perron YG; Minor WF; Bierwagen ME; Ridlon SA; Pindell MH
    J Med Chem; 1966 Jan; 9(1):136-40. PubMed ID: 4381173
    [No Abstract]   [Full Text] [Related]  

  • 31. Biogenic amine hypotheses of affective disorders.
    Garver DL; Davis JM
    Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
    [No Abstract]   [Full Text] [Related]  

  • 32. Current theories on the mode of action of antidepressant drugs.
    Carlsson A
    Adv Biochem Psychopharmacol; 1984; 39():213-21. PubMed ID: 6235723
    [No Abstract]   [Full Text] [Related]  

  • 33. Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin.
    de Montigny C; Aghajanian GK
    Science; 1978 Dec; 202(4374):1303-6. PubMed ID: 725608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antidepressant drugs on serotonergic and adrenergic receptors.
    Tang SW; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):255-61. PubMed ID: 7393341
    [No Abstract]   [Full Text] [Related]  

  • 35. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect.
    Lapin IP; Oxenkrug GF
    Lancet; 1969 Jan; 1(7586):132-6. PubMed ID: 4178247
    [No Abstract]   [Full Text] [Related]  

  • 36. U-43,465F: a triazolobenzodiazepine with pronounced antidepressant-like as well as anxiolytic activities in animals.
    Von Voigtlander PF; Puech AJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):60-76. PubMed ID: 6141773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs.
    Jenck F; Moreau JL; Mutel V; Martin JR; Haefely WE
    Eur J Pharmacol; 1993 Feb; 231(2):223-9. PubMed ID: 8453978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
    Wesołowska A; Nikiforuk A; Stachowicz K
    Eur J Pharmacol; 2006 Dec; 553(1-3):185-90. PubMed ID: 17097082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission.
    Blier P; de Montigny C; Chaput Y
    Clin Neuropharmacol; 1988; 11 Suppl 2():S1-10. PubMed ID: 2846168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.